Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Adial Pharmaceuticals, Inc. (ADIL) have performed compared to their sector so far this year.

As the software selloff deepens, ServiceNow’s CEO is buying the dip and joining others at his company in ending automated stock-selling plans.

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age.